This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Hain Celestial's (HAIN) Q2 Earnings Beat Estimates, Sales Soft
by Zacks Equity Research
Hain Celestial (HAIN) posts mixed results for second-quarter fiscal 2022. HAIN witnesses inflation, and industry-wide distribution and warehousing costs in the quarter.
3 Reasons Growth Investors Will Love Medifast (MED)
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Tyson Foods (TSN) Q1 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Tyson Foods' (TSN) first-quarter fiscal 2022 sales and earnings rise year over year on revenue growth across all the segments.
Clorox (CLX) Dips as Q2 Earnings Lag Estimates, Lowers View
by Zacks Equity Research
Clorox (CLX) Q2 results hurt by soft sales performance across all segments, led by lower shipment volumes. Higher costs also hurt the bottom line.
Post Holdings' (POST) Q1 Earnings Miss on Cost Woes, Sales Beat
by Zacks Equity Research
Post Holdings' (POST) Q1 performance reflects gains from acquisitions and net sales growth across all the reporting segments. However, cost inflation and supply chain woes remain headwinds.
Are These Consumer Staples Stocks Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Hershey's (HSY) Q4 Earnings Beat Estimates, Sales Increase Y/Y
by Zacks Equity Research
Hershey (HSY) posts solid fourth-quarter 2021 results on gains from the buyouts and higher prices. All three segments witness growth in the quarter.
Constellation Brands (STZ) Looks Well-Placed for Growth in 2022
by Zacks Equity Research
Constellation Brands (STZ) looks well-poised for growth on solid beer unit, strong demand and premiumization strategy. However, freight costs and weak wine & spirits unit concerns.
Bank on Rising P/E Investing With These 5 Top-Ranked Stocks
by Sanghamitra Saha
Want to try a different approach? Tap five stocks with increasing P/E ratios such as MEDIFAST (MED), JAKKS Pacific (JAKK), Asbury Automotive Group (ABG), Zymeworks (ZYME) and Polaris (PII).
Mondelez (MDLZ) Q4 Earnings Miss Estimates, Revenues Beat Y/Y
by Vrishali Bagree
Mondelez's (MDLZ) fourth-quarter 2021 results reflect higher earnings and revenues, with the latter gaining on buyouts and strong organic revenues.
Diageo (DEO) 1H FY22 Earnings & Sales Improve on Robust Trends
by Zacks Equity Research
Diageo's (DEO) first-half fiscal 2022 results reflect gains from continued recovery in the on-trade channel, strong consumer demand in the off-trade and market share growth.
Church & Dwight (CHD) Q4 Earnings Top Estimates, Sales Rise
by Zacks Equity Research
Church & Dwight's (CHD) fourth-quarter 2021 performance reflects net sales and earnings growth on solid consumption for the company's brands.
Colgate (CL) Earnings in Line, Sales Miss Estimates in Q4
by Zacks Equity Research
Colgate's (CL) Q4 results reflect strong business momentum, particularly in the oral care and pet nutrition categories. Results gain from price increases and stable volume amid ongoing supply woes.
Altria (MO) Q4 Earnings Match Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Altria Group's (MO) fourth-quarter 2021 results reflect an increased bottom line, while the top line declines year over year. Pricing remains an upside.
McCormick's (MKC) Q4 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
McCormick's (MKC) fourth-quarter fiscal 2021 results reflect the impact of higher sales driven by growth in the Flavor Solutions and Consumer units. Also, earnings increase in the quarter.
Medifast (MED) Looks Great on OPTAVIA, Strategic Investments
by Zacks Equity Research
Medifast (MED) has been benefiting from the strength of its OPTAVIA lifestyle solution and coaching support system, as well as efficient technological investments.
Zacks.com featured highlights include: MEDIFAST, Children's Place Inc., Pool Corp., AllianceBernstein and Expeditors International of Washington
by Zacks Equity Research
MEDIFAST, Children's Place Inc., Pool Corp., AllianceBernstein and Expeditors International of Washington are included in this blog.
Archer Daniels (ADM) Beats Earnings & Revenue Estimates in Q4
by Zacks Equity Research
Archer Daniels' (ADM) Q4 results reflect gains from healthy product demand, robust crush margins, strength in the Nutrition segment and improved productivity.
5 Top DuPont-Assured Quality Stocks to Beat Volatility
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
Tyson Foods' (TSN) Capacity Expansion Aids, High Costs Persist
by Zacks Equity Research
Tyson Foods (TSN) is on track with capacity expansion and automation technology investments. Also, it is focused on higher protein production.
Procter & Gamble (PG) Beats on Q2 Earnings & Sales, Ups View
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results gain from the rising demand for cleaning products due to the resurgence of COVID-19 cases, robust sales growth and pricing gains. Management raises the fiscal 2022 view.
Are These Consumer Staples Stocks Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Kraft Heinz's (KHC) Operating Model & Pricing Efforts Solid
by Zacks Equity Research
Kraft Heinz (KHC) is committed to its operating model, which incorporates five key elements. Also, solid pricing initiatives are yielding.
Nu Skin (NUS) Shines on Solid Sales Leaders & Customer Network
by Zacks Equity Research
Nu Skin Enterprises (NUS) has been benefiting from its efforts to empower sales leaders and strengthen the customer base.
Campbell Soup (CPB) Focuses on Saving Efforts Amid High Costs
by Zacks Equity Research
Campbell Soup (CPB) has been gaining on its strategic priorities as well as saving efforts amid rising cost inflation.